Urogenital atrophy

Climacteric

Volumn 12, Issue 4, 2009, Pages 279-285

  Calleja Agius, J ^a   Brincat, M P ^a  

^a MATER DEI HOSPITAL   (Malta)

Author keywords

Estrogen; Menopause; Urogenital atrophy; Vulvar and vaginal dryness

Indexed keywords

ESTRADIOL; ESTROGEN; KAMPO; LASOFOXIFENE; LUBRICATING AGENT; PHENYLPROPANOLAMINE; RALOXIFENE; STEROID; TAMOXIFEN;

ACUPUNCTURE; CLIMACTERIUM; CONTACT DERMATITIS; DRUG EFFICACY; DYSPAREUNIA; ESTROGEN THERAPY; FEMALE; HERBAL MEDICINE; HUMAN; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LIFESTYLE MODIFICATION; NEURODERMATITIS; NOCTURIA; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SUPPLEMENTATION; URGE INCONTINENCE; URINARY TRACT INFECTION; UROGENITAL ATROPHY; VAGINA ATROPHY; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINAL DRYNESS; VAGINAL PRURITUS;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; DERMATITIS; DYSPAREUNIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PRURITUS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; URINARY TRACT INFECTIONS; UROGENITAL SYSTEM; VAGINAL DISEASES; VULVA; VULVAR DISEASES;

EID: 70350614554     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130902814751     Document Type: Review

References (42)

1. Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997;104:87-91
2. Barlow DH, Samsioe G, van Geelen JM. A study of European women's experience of the problems of urogenital ageing and its management. Maturitas 1997;27:239-247
3. Hextall A, Cardozo L. The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:258-261
4. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090-3096
5. O'Connell TX, Nathan LS, Satmary WA, Goldstein AT. Non-neoplastic epithelial disorders of the vulva. Am Fam Physician 2008; 77:321-326
6. Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 2004;49:292-303
7. Milsom I, Arvidsson L, Ekelund P, Molander U, Eriksson O. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 1993;72:286-291
8. Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 1991;164:94-100
9. Bachmann G, Cheng RJ, Rovner E. Vulvovaginal complaints. In Lobo RA, ed. Treatment of the Postmenopausal Woman. New York: Elsevier, 2007:263-269
10. Panay N. Menopause and the postmenopausal woman. In Edmonds DK, ed. Dewhurst's Textbook of Obstetrics and Gynaecology. Oxford: Blackwell Publishing, 2008:479-495
11. Bachmann GA, Leiblum SR, Kemmann E, Colburn DW, Swartzman L, Shelden R. Sexual expression and its determinants in the postmenopausal woman. Maturitas 1984;6:19-29
12. Semmens JP, Tsai CC, Semmens EC, Loadholt CB. Effects of estrogen therapy on vaginal physiology during menopause. Obstet Gynecol 1985;66:15-18
13. Oriba HA, Maibach HI. Vulvar transepidermal water loss (TEWL) decay curves. Effect of occlusion, delipidation, and age. Acta Derm Venereol 1989;69:461-465
14. Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982;248:445-448
15. van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50- 75 years. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:9-14
16. Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol 1989;73:425-427
17. Burger H, Hailes J, Nelson J, Menelaus M. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. Br Med J (Clin Res Ed) 1987;294:936-937 (Pubitemid 17051529)
18. Hextall A, Cardozo L. Managing postmenopausal cystitis. Hosp Pract (Minneap) 1997;32: 191-198
19. Robinson D, Cardozo L. Urinary incontinence. In Edmonds DK, ed. Dewhurst's Textbook of Obstetrics and Gynaecology. Oxford: Blackwell Publishing, 2007:504-559
20. Farage M, Maibach H. Lifetime changes in the vulva and vagina. Arch Gynecol Obstet 2006;273:195-202
21. Versi E, Harvey MA, Cardozo L, Brincat M, Studd JW. Urogenital prolapse and atrophy at menopause: a prevalence study. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:107-110
22. Nevin JE, Pharr ME. Preventive care for the menopausal woman. Prim Care 2002;29: 583-597
23. Carranza-Lira S, Fragoso-Diaz N, MacGregor- Gooch AL, Garduno-Hernandez MP, Rios-Calderon K, Aparicio H. Vaginal dryness assessment in postmenopausal women using pH test strip. Maturitas 2003;45:55-58
24. Amin SH, Kuhle CL, Fitzpatrick LA. Comprehensive evaluation of the older woman. Mayo Clin Proc 2003;78:1157-1185
25. Staughton R. Benign disease of the vulva. In Edmonds DK, ed. Dewhurst's Textbook of Obstetrics and Gynaecology. Oxford: Blackwell Science, 2007:578-590
26. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004. Int J Gynaecol Obstet 2005; 88:22-28
27. Johnston SL, Farrell SA, Bouchard C, et al. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26:503-515
28. Ayton RA, Darling GM, Murkies AL, et al. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 1996;103:351-358
29. Weisberg E, Ayton R, Darling G, et al. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005;8:83-92
30. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;71:73-80
31. Gabrielsson J, Wallenbeck I, Birgerson L. Pharmacokinetic data on estradiol in light of the Estring concept. Estradiol and Estring pharmacokinetics. Acta Obstet Gynecol Scand Suppl 1996;163:26-31
32. Robinson D, Cardozo L. The menopause and HRT. Urogenital effects of hormone therapy. Best Pract Res Clin Endocrinol Metab 2003; 17:91-104
33. Cardozo L, Robinson D. Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder. Urology 2002;60(5 Suppl 1):64-71 (Pubitemid 36009221)
34. Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003;62(4 Suppl 1):45-51
35. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-727
36. Wang XN, Simmons HA, Salatto CT, Cosgrove PG, Thompson DD. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats. Menopause 2006;13: 609-620
37. Kaufert P, Boggs PP, Ettinger B, Woods NF, Utian WH. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998;5:197-202
38. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Use of botanicals for management of menopausal symptoms. Obstet Gynecol 2001;97: Suppl 11
39. Chung MH, Suzuki S, Nishihara T, Hattori M. Estrogenic effects of a Kampo formula, Tokishakuyakusan, in parous ovariectomized rats. Biol Pharm Bull 2008;31:1145-1149
40. Martin-Alguacil N, Pfaff DW, Kow LM, Schober JM. Oestrogen receptors and their relation to neural receptive tissue of the labia minora. BJU Int 2008;101:1401-1406
41. Yildirim B, Kaleli B, Duzcan E, Topuz O. The effects of postmenopausal vitamin D treatment on vaginal atrophy. Maturitas 2004;49:334-337
42. Pitkin J, Rees MC, Gray S, et al. Nonestrogen- based treatments for menopausal symptoms. Menopause Int 2008;14:88-90